NIH-funded translational research centers to speed, diversify Alzheimer's drug discovery— NIA has launched two new research centers designed to diversify and reinvigorate the Alzheimer’s disease drug development pipeline.
¿Cómo manejar el “destete” de los análogos GLP-1?
Hace 22 horas


No hay comentarios:
Publicar un comentario